Agilent Technologies (NYSE:A) Updates Q4 2026 Earnings Guidance

Agilent Technologies (NYSE:A) issued an update on its fourth quarter 2026 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 1.710-1.740 for the period, compared to the consensus earnings per share estimate of 1.710. The company issued revenue guidance of $2.0 billion-$2.0 billion, compared to the consensus revenue estimate of $2.0 billion. Agilent Technologies also updated its FY 2026 guidance to 6.180-6.210 EPS.

Agilent Technologies Stock Up 1.6%

Shares of Agilent Technologies stock opened at $157.60 on Friday. Agilent Technologies has a one year low of $108.35 and a one year high of $163.75. The company has a market cap of $44.51 billion, a P/E ratio of 31.02, a PEG ratio of 2.74 and a beta of 1.25. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. The firm has a fifty day moving average of $139.76 and a two-hundred day moving average of $126.85.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.84%. The business had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.84 billion. During the same quarter in the previous year, the firm earned $1.37 earnings per share. The business’s quarterly revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, analysts forecast that Agilent Technologies will post 6.05 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the company. Morgan Stanley lifted their price objective on Agilent Technologies from $160.00 to $175.00 and gave the company an “overweight” rating in a report on Wednesday, August 12th. TD Cowen raised their price target on Agilent Technologies from $155.00 to $180.00 and gave the company a “buy” rating in a report on Thursday. The Goldman Sachs Group raised their price target on Agilent Technologies from $155.00 to $175.00 and gave the company a “buy” rating in a report on Thursday. HSBC dropped their price objective on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Wednesday, June 3rd. Finally, Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Sunday, August 2nd. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat, Agilent Technologies currently has a consensus rating of “Moderate Buy” and an average target price of $170.33.

Agilent Technologies News Summary

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent exceeded quarterly expectations. Fiscal Q3 revenue rose 8.1% year over year to $1.88 billion, above the $1.84 billion consensus estimate. Non-GAAP EPS was $1.62, ahead of the $1.49 estimate and up from $1.37 a year earlier. GAAP net income reached $362 million, or $1.28 per share. Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: Management raised its fiscal 2026 outlook. Full-year adjusted EPS guidance increased to $6.18-$6.21, above the $6.06 analyst consensus, while revenue guidance of approximately $7.5 billion also exceeded expectations. Fourth-quarter EPS guidance of $1.71-$1.74 was at or above consensus. Agilent raises annual profit forecast on improving lab tools demand
• Positive Sentiment: Growth and operating leverage are improving. Operating profit rose 23.3% to $444 million, while operating cash flow increased 43.4% to $519 million. Commentary highlighted product momentum, recovering Chinese demand and margin expansion as drivers of the stronger performance. A Q2 Deep Dive: Product Momentum, China Recovery, and Operating Leverage Drive Results
• Positive Sentiment: Analyst sentiment strengthened materially. Citigroup, JPMorgan, RBC, Stifel, Bank of America, Goldman Sachs, Barclays, TD Cowen and Bernstein all raised price targets, with new targets generally ranging from $175 to $190 and buy, overweight or outperform ratings. Analyst price-target updates
• Neutral Sentiment: At roughly 31 times earnings and near its 52-week high, Agilent’s valuation already reflects considerable optimism. Sustaining the rally will likely depend on continued demand recovery and delivery of the raised guidance.

Institutional Investors Weigh In On Agilent Technologies

Several institutional investors have recently modified their holdings of A. State of Wyoming purchased a new position in Agilent Technologies in the 2nd quarter valued at approximately $35,000. Transamerica Financial Advisors LLC grew its holdings in Agilent Technologies by 180.8% during the 4th quarter. Transamerica Financial Advisors LLC now owns 337 shares of the medical research company’s stock valued at $46,000 after buying an additional 217 shares during the last quarter. Johnson Financial Group Inc. acquired a new stake in shares of Agilent Technologies during the 3rd quarter worth about $49,000. DV Equities LLC acquired a new stake in shares of Agilent Technologies during the fourth quarter worth $54,000. Finally, Itau Unibanco Holding S.A. purchased a new stake in Agilent Technologies in the 4th quarter valued at about $58,000.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.